Peer-reviewed Publications (Original research)

Peer-reviewed Publications (Original research)

• Inoue K, Liu M, Aggarwal R, Marinacci LX, Wadhera RK.(2025) Prevalence and Control of Diabetes Among US Adults, 2013 to 2023. JAMA. (Online ahead of print)
• Komura T, Bargagli-Stoffi FJ, Shiba K, Inoue K. Two-Step Pragmatic Subgroup Discovery for Heterogeneous Treatment Effects Analyses: Perspectives Toward Enhanced Interpretability. Eur J Epidemiol. (Online Ahead of Print) Identifying heterogeneity
• Nianogo RA, O'Neill S, Inoue K. Generalized framework for identifying meaningful heterogenous treatment effects in observational studies: A parametric data-adaptive G-computation approach. J Stat Methods Med Res. (Online ahead of print) Identifying heterogeneity
• Inoue K, Kazi DS, Vaduganathan M, Marinacci LX, Wadhera RK.(2025) Prescription Patterns for GLP-1 Receptor Agonists and SGLT2 Inhibitors by Physicians’ Years in Practice. J Gen Intern Med. (Online ahead of print)
• Inoue K, Sakamaki K, Komukai S, Ito Y, Goto A, Shinozaki T. (2025) Confounder Selection and Sensitivity Analyses to Unmeasured Confounding from Epidemiological and Statistical Perspectives. Journal of Epidemiology. 35(1):3-10
• Mori Y, Komura T, Adomi M, Yagi R, Fukuma S, Kondo N, Yanagita M, Duru OK, Tuttle KR, Inoue K*.(2024) Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Events Among Patients with Type 2 Diabetes and Low-to-Normal Body Mass Index: A Nationwide Cohort Study with Target Trial Emulation. Cardiovascular Diabetology. 23(1):372.
• Harii K, Inoue K*, Bacong AM, Kondo N.(2024) State-Level Anti-Asian Hate Crimes and Mental Health among Asian and Other Racial Groups in the US. Social Science & Medicine. 364:117494.
• Komura Y, Inoue K*, Ishimura N, Taura D, Harada N, Inagaki N, Kondo N.(2024) Diabetes and Suicide: A Nationwide Longitudinal Cohort Study among the Japanese Working-age Population. Journal of Epidemiology and Community Health. (Online ahead of print)
• Kitamoto T, Ruike Y, Koide H, Inoue K, Maezawa Y, Omura M, Nakai K, Tsurutani Y, Saito J, Kuwa K, Yokote K, Nishikawa T.(2024) Shifting Paradigms in Primary Aldosteronism: Reconsideration of Screening Strategy via Integrating Pathophysiological Insights. Frontiers in Endocrinology.15:1372683.
• Yoshihara A, Noh JY, Inoue K, Koshibu M, Hirose R, Ichikawa M, Matsumoto M, Suzuki N, Fukushita M, Watanabe N, Sugino K, Ito K.(2024) Long-term outcomes after a radioactive iodine treatment for a single autonomous functioning thyroid nodule in Japan. Endocrine Journal. (Online ahead of print)
• Nishi A,Inoue K.(2024) What Epidemiologists Can Do in the Era of Machine Learning and Artificial Intelligence. Journal of Epidemiology. (Online ahead of print)
• Xia T, Nianogo RA, Yu Q, Horwich T, Srikanthan P, Inoue K, Allison M, Zhang ZF, Watson KE, Chen L.(2024) Racial disparities of type 2 diabetes through exercise: The Multi-Ethnic Study of Atherosclerosis. Am J Prev Med. (Online ahead of print)
• Inoue K*, Athey S, Baicker K, Tsugawa Y. (2024) Heterogeneous effects of Medicaid coverage on cardiovascular risk factors: secondary analysis of randomized controlled trial. BMJ. 386: e079377. Identifying heterogeneity
• Inoue K*, Adomi M, Efthimiou O, Komura T, Omae K, Onishi A, Tsutsumi Y, Fujii T, Kondo N, Furukawa AT. (2024) Machine Learning Approaches to Evaluate Heterogeneous Treatment Effects in Randomized Controlled Trials: A Scoping Review. J Clin Epidemiol. 4(1):247. Identifying heterogeneity
• Mori Y, Inoue K*, Sato H, Tsushima T, Fukuma S. (2024) Beta-blocker initiation under dobutamine infusion in acute advanced heart failure: a target trial emulation with observational data. Eur Heart J Open. 4(4): oeae054.
• Mori Y, Fukuma S, Yamaji K, Mizuno A, Kondo N, Inoue K*. (2024) Machine Learning-based Prediction of Elevated NT-pro BNP among US General Population. ESC Heart Failure. (Online ahead of print).
• Saito Y, Matsuzu K, Takami H, Inoue K*, Shibuya H, Kuga Y, Matsui A, Ono R, Yoshioka K, Masaki C, Akaishi J, Hames K, Okamura R, Tomoda C, Suzuki A, Kitagawa W, Nagahama M, Sugino K, Ito K. (2024) Prognosis after lobectomy vs. total thyroidectomy with ipsilateral LND for N1b intermediate-risk PTC. JAMA Otolaryngol Head Neck Surg. (Online ahead of print).
• Yagi R, Mori Y, Goto S, Iwami T, Inoue K*.(2024) Routine Electrocardiogram Screening and Cardiovascular Disease Events in Adults. JAMA Internal Medicine. 184(9):1035-1044.
• Inoue K, Bashir MT, Warner AL, Ebrahimi R, Neverova NV, Currier JW, Sohn SY, Rhee CM, Lee ML, Leung AM.(2024) Cardiac Electrical and Structural Changes After Iodinated Contrast Media Administration: A Longitudinal Cohort Analysis. Thyroid. 34(9):1163-1170.
• Komura T, Tsugawa Y, Mayeda ER, Glymour MM, Inoue K*.(2024) Association of Cardiovascular Events with Spouse’s Subsequent Dementia. JAMA Neurology. 81(10):1098-1099.
• Naito T, Inoue K (co-first), Namba S, Sonehara K, Suzuki K, BioBank Japan, Yamamoto K, Baba R, Kodama T, Otagaki Y, Okada A, Itcho K, Kobuke K, Ohno H, Biobank Japan, Matsuda K, Kondo N, Toda T, Yamauchi T, Kadowaki T, Okada Y.(2024) A machine learning approach reveals heterogeneous association of environmental factors with diseases across polygenic risk scores: an application to cardiovascular diseases and type 2 diabetes. Communications Medicine. 4(181)
• Sohn SY, Inoue K, Rhee CM, Leung AM.(2024) Risks of Iodine Excess. Endocrine Reviews. 45(6):858-879.
• Inoue K. (2024) Causal Inference and Machine Learning in Endocrine Epidemiology. Endocrine Journal. 71(10):945-953.
• Kiyohara K, Kondo N, Iwami T, Yano Y, Nishiyama A, Node K, Inagaki N, Duru OK, Inoue K. (2024) Heterogeneous Effects of Intensive Glycemic and Blood Pressure on Cardiovascular Events among Diabetes by Living Arrangements. J. Am. Heart Assoc. 13(13): e033860.
• Inoue K, Naito T, Fujii R, Sonehara K, Yamamoto K, Baba R, Kodama T, Otagaki Y, Okada A, Itcho K, Kobuke K, Ohno H, Biobank Japan, Morisaki T, Hattori N, Goto A, Nishikawa T, Oki K, Okada Y. (2024) Primary aldosteronism and risk of cardiovascular outcomes: Genome-wide association and Mendelian randomization study. J. Am. Heart Assoc. 13(15):e034180.
• Kato H, Kitamoto T, Kimura S, Sunouchi T, Hoshino Y, Hidaka N, Tsurutani Y, Ito N, Makita N, Nishikawa T, Nangaku M, Inoue K. (2024) Cardiovascular Outcomes of KCNJ5 mutated Aldosterone-Producing Adenoma: A Systematic Review. Endocrine Practice. 30(7):670-678.
• Tanaka S, Muramatsu Y, Inoue K. (2024) Clarifying causal effects of interest and underlying assumptions in randomized and nonrandomized clinical trials in oncology using directed acyclic graphs and single world intervention graphs. JCO Clinical Cancer Informatics. e2300262.
• Sohn SY, Inoue K, Bashir MT, Currier JW, Neverova NV, Ebrahimi R, Rhee CM, Lee ML, Leung AM. (2024) Thyroid Dysfunction Risk After Iodinated Contrast Media Administration: A Prospective Longitudinal Cohort Analysis. J Clin Endocrinol Metab. (Online ahead of print)
• Noh JY, Inoue K, Suzuki N, Yoshihara A, Fukushita M, Matsumoto M, Imai H, Hiruma S, Ichikawa M, Koshibu M, Sankoda A, Hirose R, Watanabe N, Sugino K, Ito K. (2024) Dose-Dependent Incidence of Agranulocytosis in Patients Treated with Methimazole and Propylthiouracil. Endocrine Journal. 71(7):695-703.
• Ikesu R, Wu Y, Zimmerman SC, Inoue K, Buto P, Power MC, Schaefer CA, Glymour MM, and Mayeda ER. (2024) Representativeness of participants in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial compared to middle-aged and older adults living with diabetes in the United States. Epidemiology. 35(4):432-436.